All Stories

  1. Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant
  2. Impact of IGF-I release kinetics on bone healing: A preliminary study in sheep
  3. Biocompatibility and osteoconduction of macroporous silk fibroin implants in cortical defects in sheep
  4. Remodeling of tissue-engineered bone structures in vivo
  5. Electrospun matrices for localized drug delivery: Current technologies and selected biomedical applications
  6. Surface assembly of poly(I:C) on PEGylated microspheres to shield from adverse interactions with fibroblasts
  7. Tuning the immune response of dendritic cells to surface-assembled poly(I:C) on microspheres through synergistic interactions between phagocytic and TLR3 signaling
  8. Silk fibroin as a vehicle for drug delivery applications
  9. The use of sulfonated silk fibroin derivatives to control binding, delivery and potency of FGF-2 in tissue regeneration
  10. Design and validation of a novel bioreactor principle to combine online micro-computed tomography monitoring and mechanical loading in bone tissue engineering
  11. Silk fibroin/hyaluronan scaffolds for human mesenchymal stem cell culture in tissue engineering
  12. Biopolymer-Based Growth Factor Delivery for Tissue Repair: From Natural Concepts to Engineered Systems
  13. Concomitant delivery of a CTL-restricted peptide antigen and CpG ODN by PLGA microparticles induces cellular immune response
  14. Optimization strategies for electrospun silk fibroin tissue engineering scaffolds
  15. Microporous silk fibroin scaffolds embedding PLGA microparticles for controlled growth factor delivery in tissue engineering
  16. PEGylation as a tool for the biomedical engineering of surface modified microparticles
  17. Silk fibroin spheres as a platform for controlled drug delivery
  18. Mannose-Based Molecular Patterns on Stealth Microspheres for Receptor-Specific Targeting of Human Antigen-Presenting Cells
  19. CONTROL OF TISSUE-ENGINEERED BONE-LIKE STRUCTURES ON SILK FIBROIN SCAFFOLDS
  20. Controlled nerve growth factor release from multi-ply alginate/chitosan-based nerve conduits
  21. Metabolic Cleavage and Translocation Efficiency of Selected Cell Penetrating Peptides: A Comparative Study with Epithelial Cell Cultures
  22. Insulin-like growth factor I releasing silk fibroin scaffolds induce chondrogenic differentiation of human mesenchymal stem cells
  23. Cotton wool-like nanocomposite biomaterials prepared by electrospinning:In vitrobioactivity and osteogenic differentiation of human mesenchymal stem cells
  24. The effect of hyaluronic acid on silk fibroin conformation
  25. Dendronised block copolymers as potential vectors for gene transfection
  26. On The Biomedical Promise of Cell Penetrating Peptides: Limits Versus Prospects
  27. Stable Stealth Function for Hollow Polyelectrolyte Microcapsules through a Poly(ethylene glycol) Grafted Polyelectrolyte Adlayer
  28. Silk coatings on PLGA and alginate microspheres for protein delivery
  29. A Protective Allergy Vaccine Based on CpG- and Protamine-Containing PLGA Microparticles
  30. Non-Invasive Time-Lapsed Monitoring and Quantification of Engineered Bone-Like Tissue
  31. Nerve conduits and growth factor delivery in peripheral nerve repair
  32. A Protective Allergy Vaccine Based on CpG- and Protamine-Containing PLGA Microparticles
  33. Differentiation Restricted Endocytosis of Cell Penetrating Peptides in MDCK Cells Corresponds with Activities of Rho-GTPases
  34. The preservation of phenotype and functionality of dendritic cells upon phagocytosis of polyelectrolyte-coated PLGA microparticles
  35. Control of in vitro tissue-engineered bone-like structures using human mesenchymal stem cells and porous silk scaffolds
  36. Reviewing Biophysical and Cell Biological Methodologies in Cell-Penetrating Peptide (CPP) Research
  37. Erratum: Reviewing Biophysical and Cell Biological Methodologies in Cell-Penetrating Peptite (CPP) Research (Volume 24, Issue 3)
  38. Hydrogel nerve conduits produced from alginate/chitosan complexes
  39. Cartilage-like Tissue Engineering Using Silk Scaffolds and Mesenchymal Stem Cells
  40. Osteogenesis by human mesenchymal stem cells cultured on silk biomaterials: Comparison of adenovirus mediated gene transfer and protein delivery of BMP-2
  41. Cartilage-like Tissue Engineering Using Silk Scaffolds and Mesenchymal Stem Cells
  42. Encapsulation of proteins and peptides into biodegradable poly(d,l-lactide-co-glycolide) microspheres prolongs and enhances antigen presentation by human dendritic cells
  43. One-step preparation of polyelectrolyte-coated PLGA microparticles and their functionalization with model ligands
  44. The Cell Penetrating Peptides pVEC and W2-pVEC Induce Transformation of Gel Phase Domains in Phospholipid Bilayers without Affecting Their Integrity †
  45. Effects of structural modification on gene transfection and self-assembling properties of amphiphilic dendrimers
  46. Continuous contact- and contamination-free ultrasonic emulsification—a useful tool for pharmaceutical development and production
  47. Phagocytosis of poly(L-lysine)-graft-poly(ethylene glycol) coated microspheres by antigen presenting cells: Impact of grafting ratio and poly(ethylene glycol) chain length on cellular recognition
  48. Membrane Surface-Associated Helices Promote Lipid Interactions and Cellular Uptake of Human Calcitonin-Derived Cell Penetrating Peptides
  49. Bilayer interaction and localization of cell penetrating peptides with model membranes: A comparative study of a human calcitonin (hCT)-derived peptide with pVEC and pAntp(43–58)
  50. Insulin-like Growth Factor I—Releasing Alginate-Tricalciumphosphate Composites for Bone Regeneration
  51. Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology
  52. Transport Of Surface-Modified Nanoparticles Through Cell Monolayers
  53. Decoding the Entry of Two Novel Cell-Penetrating Peptides in HeLa Cells:  Lipid Raft-Mediated Endocytosis and Endosomal Escape
  54. Transfection of a mouse dendritic cell line by plasmid DNA-loaded PLGA microparticles in vitro
  55. Concepts and Prototypes for Formulation and Delivery of Biopharmaceuticals and in Tissue Engineering
  56. Modulation of allergic responses in mice by using biodegradable poly(lactide-co-glycolide) microspheres
  57. Metabolic cleavage of cell-penetrating peptides in contact with epithelial models: human calcitonin (hCT)-derived peptides, Tat(47–57) and penetratin(43–58)
  58. Localized delivery of growth factors for bone repair
  59. Chances and pitfalls of cell penetrating peptides for cellular drug delivery
  60. Composition and Surface Charge of DNA-Loaded Microparticles Determine Maturation and Cytokine Secretion in Human Dendritic Cells
  61. Cellular Uptake But Low Permeation of Human Calcitonin-Derived Cell Penetrating Peptides and Tat(47-57) Through Well-Differentiated Epithelial Models
  62. Phenotype and functional analysis of human monocyte-derived dendritic cells loaded with biodegradable poly(lactide-co-glycolide) microspheres for immunotherapy
  63. Ultrasonic atomisation into reduced pressure atmosphere—envisaging aseptic spray-drying for microencapsulation
  64. Immobilisation of GM-CSF onto particulate vaccine carrier systems
  65. Cellular Internalization of Human Calcitonin Derived Peptides in MDCK Monolayers: A Comparative Study with Tat(47-57) and Penetratin(43-58)
  66. Localized insulin-like growth factor I delivery to enhance new bone formation
  67. Evaluation of pH-dependent membrane-disruptive properties of poly(acrylic acid) derived polymers
  68. An experimental divalent vaccine based on biodegradable microspheres induces protective immunity against tetanus and diphtheria
  69. Amphiphilic Dendrimers: Novel Self-Assembling Vectors for Efficient Gene Delivery
  70. Improved Stimulation of Human Dendritic Cells by Receptor Engagement with Surface-modified Microparticles
  71. Evaluation of cationic solid lipid microparticles as synthetic carriers for the targeted delivery of macromolecules to phagocytic antigen-presenting cells
  72. In vitro methodologies to study nasal delivery using excised mucosa
  73. A crystal clear solution for insulin delivery
  74. Phagocytosis of synthetic particulate vaccine delivery systems to program dendritic cells
  75. Cellular Internalization of Enhanced Green Fluorescent Protein Ligated to a Human Calcitonin-Based Carrier Peptide
  76. In vitro phagocytosis and monocyte-macrophage activation with poly(lactide) and poly(lactide-co-glycolide) microspheres
  77. Compromised integrity of excised porcine intestinal epithelium obtained from the abattoir affects the outcome of in vitro particle uptake studies
  78. In Vitro Assessment of Intestinal IGF‐I Stability
  79. Microparticle-mediated Transfection of Non-phagocytic Cells In Vitro
  80. Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages?
  81. Hydrophilic poly(dl-lactide-co-glycolide) microspheres for the delivery of DNA to human-derived macrophages and dendritic cells
  82. Release kinetics and immunogenicity of parvovirus microencapsulated in PLA/PLGA microspheres
  83. Stabilizing insulin-like growth factor-I in poly(d,l-lactide-co-glycolide) microspheres
  84. Technological considerations related to the up-scaling of protein microencapsulation by spray-drying
  85. Control of gentamicin release from a calcium phosphate cement by admixed poly(acrylic acid)
  86. Control of Gentamicin Release From a Calcium Phosphate Cement by Admixed Poly(acrylic acid)
  87. Formulation of sustained release aqueous Zn–hirudin suspensions
  88. Modeling of Diffusion and Concurrent Metabolism in Cutaneous Tissue
  89. In vitro and in vivo evaluation of a somatostatin analogue released from PLGA microspheres
  90. Validation of Excised Bovine Nasal Mucosa as In Vitro Model to Study Drug Transport and Metabolic Pathways in Nasal Epithelium‡‡Data adopted from yet unpublished parts of the Ph.D. theses of Günter Ditzinger, Steffen Lang, and M. Christiane Schmidt
  91. Immunogenicity of single-dose diphtheria vaccines based on PLA/PLGA microspheres in guinea pigs
  92. Microencapsulation of DNA using poly(dl-lactide-co-glycolide): stability issues and release characteristics
  93. Function and immunolocalization of overexpressed human intestinal H+/peptide cotransporter in adenovirus-transduced Caco-2 cells
  94. Sustained release of heparin from polymeric particles for inhibition of human vascular smooth muscle cell proliferation
  95. The venus flytrap of periplasmic binding proteins: An ancient protein module present in multiple drug receptors
  96. Diphtheria and tetanus toxoid microencapsulation into conventional and end-group alkylated PLA/PLGAs
  97. MHC class I- and class II-restricted processing and presentation of microencapsulated antigens
  98. Translocation of Human Calcitonin in Respiratory Nasal Epithelium Is Associated with Self-Assembly in Lipid Membrane
  99. Physico-chemical and antigenic properties of tetanus and diphtheria toxoids and steps towards improved stability
  100. Mechanistic and Quantitative Prediction of Aminopeptidase Activity in Stripped Human Skin Based on the HaCaT Cell Sheet Model
  101. P-Glycoprotein (P-gp) Mediated Efflux in Caco-2 Cell Monolayers: The Influence of Culturing Conditions and Drug Exposure on P-gp Expression Levels
  102. Sustained release of injectable zinc-recombinant hirudin suspensions: development and validation of in vitro release model
  103. Drug Microencapsulation by PLA/PLGA Coacervation in the Light of Thermodynamics. 1. Overview and Theoretical Considerations
  104. Drug Microencapsulation by PLA/PLGA Coacervation in the Light of Thermodynamics. 2. Parameters Determining Microsphere Formation
  105. Permeation and Pathways of Human Calcitonin (hCT) Across Excised Bovine Nasal Mucosa
  106. In vitro cell models to study nasal mucosal permeability and metabolism
  107. Structure-Permeation Relations of Met-enkephalin Peptide Analogues on Absorption and Secretion Mechanisms in Caco-2 Monolayers
  108. Intestinal absorption of the quaternary trospium chloride: permeability-lowering factors and bioavailabilities for oral dosage forms
  109. Gentamicin-Loaded Hydraulic Calcium Phosphate Bone Cement as Antibiotic Delivery System
  110. Epidermal Aminopeptidase Activity and Metabolism as Observed in an Organized HaCaT Cell Sheet Model
  111. Physico-chemical parameters governing protein microencapsulation into biodegradable polyesters by coacervation
  112. Localization of Aminopeptidase Activity in Freshly Excised Human Skin: Direct Visualization by Confocal Laser Scanning Microscopy
  113. Transport and Metabolic Pathway of Thymocartin (TP4) in Excised Bovine Nasal Mucosa
  114. Tetanus toxoid and synthetic malaria antigen containing poly(lactide)/poly(lactide-co-glycolide) microspheres: importance of polymer degradation and antigen release for immune response
  115. Physical Model Relating Diffusional Transport and Concurrent Metabolism of Peptides in Metabolically Active Cell Sheets
  116. Membrane modulated dissolution of oral drug delivery systems
  117. Architecture and Polymorphism of Fibrillar Supramolecular Assemblies Produced by in Vitro Aggregation of Human Calcitonin
  118. Dermal metabolism of topically applied drugs: Pathways and models reconsidered
  119. Interfacial Adsorption and Aggregation Associated Changes in Secondary Structure of Human Calcitonin Monitored by ATR-FTIR Spectroscopy
  120. New aspects of pharmaceutical dosage forms for controlled drug delivery of peptides and proteins
  121. Metabolism and Transport of the Pentapeptide Metkephamid by Brush-border Membrane Vesicles of Rat Intestine
  122. Intraoral Peptide Absorption
  123. Fluorescence study of human calcitonin fibrillation kinetics using the hydrophobic probe Nile red
  124. Buccal delivery for peptide drugs
  125. Formulation of Silicone Matrix Systems for Long Term Constant Release of Peptides
  126. Intrinsic diffusion coefficients of drugs in pressure-sensitive adhesive polymer masses
  127. Evaluation of laminated muco-adhesive patches for buccal drug delivery
  128. Drug Delivery of Peptides: The Buccal Route
  129. Modeling and Numerical Computation of Drug Transport in Laminates: Model Case Evaluation of Transdermal Delivery System
  130. Release kinetics of polymeric laminates for transdermal delivery: Experimental evaluation and physical modelling
  131. Design of oral drug delivery systems – Past, present and future
  132. Quantitative, mechanistic and physiologically realistic approach to the biopharmaceutical design of oral drug delivery systems